Summary. The endocrine function of pancreaticoduodenal allografts was studied in six dogs and compared with that of normal animals. The grafts were able %o prevent the diabetic ketosis that was observed in a control group after total pancreatectomy without following transplantation. --Systemic hyperglycaemia enhanced the insulin release from the transplanted pancreas, as measured by increased IRI levels after intravenous glucose administration. In contrast, the stimulation of insulin secretion by oral glucose loading was less than in norreal dogs, while the glucose assimilation was also increased in transplanted animals. --It was speculated that the duodenum might be more susceptible to immunological damage than the pancreas, and that consequently an impairment of the resorption of glucose and of the production of intestinal factors controlling the secretion of insulin may result. --In the near future, pancreatico-duodenal transplantation does not appears to become a therapeutical alternative to the conventional treatment of diabetes mellitus in man.
Introduction
The endocrine function of the transplanted pancreas has been repeatedly studied since 1892 when Minkowski used the technique of pedicle transplantation of a pancreatic lobe, by which he demonstrated the relationship between the pancreas and diabetes mellitus [2, 4, 6, 9, 17, 19, 20, 21 ]. An orthotopie pancreatieo-dupdenal transplantation permitting a normal exocrine as well as endocrine function of the graft was used for ~he first time by Largiad~r et al. [12, 13, 14] . The transplantation en bloc of the functionally-connected pancreatico-duodenal complex is a technique that may eventually advance to a therapeutical procedure in the surgical treatment of chronic pancreatitis, carcinoma of the pancreas and maybe also diabetes mellitus. In view of this last possibility we were prompted to study the endocrine function of these grafts. Since the dogs survived the operation for approximately three weeks, the experiments were not carried out in the immediate postoperative period when the animals did not yet feed normally and when carbohydrate metabolism was still disturbed.
The response of the graft to systemic hyperglycaemia was tested by intravenous glucose administration, and the function of the glucose-responsive "enteroinsular axis" [18] was investigated by oral glucose tolerance tests. Some of the results have previously been published in preliminary form [7] .
Materials and Methods
Adult mongrel dogs of either sex weighing between 19 and 26 kg were used. The surgical procedure for pancreatectomy and pancreatico-duodenal allotransplanration is schematically shown in Fig. 1 . The method, the surgical results and the exocrine function of the allograft have been described in detail elsewhere [12, 13, 14] . Immunosuppressive therapy consisted of daily administrations of Azathioprine (4--8 mg per kg body weight). All recipient dogs had this treatment. After the immediate postoperative period of three to four days the dogs were again fed normally. No intravenous or oral glucose tolerance tests were performed prior to the 10th postoperative day. The animals were fasted 12--16 h before the tests. Intravenous and oral glucose tolerance tests were performed by the method of Conard [5] and Arnould et al. [1] in unanaesthetized animals. Glucose was given intravenously (0.5 g/kg) or orally by gastric tube (2.0 g/kg, in a 25~o solution containing 4.25 g of NaC1).
Blood samples were obtained by venipuneture before glucose administration and every 5 to 10 rain thereafter for 50 to 75 rain. The kinetics of glucose utilization were studied as described by Arnould [1] , using the rate of disappearance of blood glucose-14C activity after intravenous injection of 40 ~Ci of glucose-U-14C. T~ of blood glucose and radioactivity was determined graphically on semilogarithmic paper.
Blood glucose was measured with glucose oxidase [3] . Plasma free fatty acids were extracted and titrated according to Gordon [8] . 14C-labelled glucose was obtained from the Radiochemical Centre, Amersham, England. It was isolated from blood in the form of osazones and counted in a low background flow counter. The values obtained were corrected for selfabsorption. Serum immunoreactive insulin was determined by a double antibody immunoassay 1.
Results

Pancreatectomy and prevention of diabetic lcetosis by pancreas transplantation
In four dogs total duodeno-panereatectomy with choledocho-duodenostomy and gastro-jejunostomy was performed, and their blood sugar, plasma free after pancreatectomy ranged between 7 and 31 days. All animals developed severe diabetes mellitus and ketosis, and finally died. The mean levels of fasting blood sugar and plasma free fatty acids between the 7th and 10th day postoperatively were 337.24-32.0 rag% and 1.334-0.05 royal/1 respectively (mean 4-SEM). In contrast, the fasting blood sugar of 3 dogs was the same before and 10 days after pancreatectomy followed by pancreas transplantation and Azathioprine therapy (78.04-3.9 rag%, 83.04-11.8 rag%). The administration of Azathioprine to control animals which were not operated upon did not influence the fasting blood sugar.
Kinetics of glucose utilization and insulin secretion in response to glucose administration. Influence of transplantation and~or Azathioprine therapy a) Oral glucose tolerance tests.
Oral glucose administration to healthy dogs normally elicits only a small rise of blood sugar, and TI~ of the 14C-activity of blood glucose varies appreciably from one animal to another. When the same a~imals were tested before Glucose assimilation before and after oral glucose in dogs with panereatieo-duodenal transplants. After intravenous injection of 40 FCi of glucose-U-laC the disappearance of blood glueose-14C-aetivity was measured before and after intragastric administration of unlabelled glucose (2 g/kg). The glucose load was given at 0 rain. One animal was tested in every group. For technical details see section on methods fatty acids and acetone were determined. The daily infusion of 1 1 of slightly hypotonic and alkaline solution (equal parts of 0.95% NaC1, 1.6 M sodium bicarbonate and distilled water) corrected fluid losses and acidosis to some extent. The survival time of the dogs 1 We are grateful to Prof. E. Fliiekiger and Dr. W. Hammer, Sandoz AG, Basel, for these determinations.
and after transplantation an increase in T~ of 14C-activity of blood glucose was apparent at each instant after glucose loading (Table 1) . Oral glucose elicited an increase in the disappearance rate of 14C-glucose in each dog in all groups. Transplantation and Azathioprine, as well as Azathioprine alone, seemed to reduce this response to glucose to some extent (Fig. 2) . Serum immunoreactive insulin was about doubled 30 min after glucose in the control group, whereas it was only insignificantly influenced in recipients of allografts (Table 1) .
b) Intravenous glucose tolerance tests. Intravenous injection of glucose resulted in a sharp increase of the blood sugar after 10 rain. 30 rain after the injection a clear-cut reduction of the blood sugar level was apparent in all animals ( Table 2) . T~ of blood glucoseitC-activity again seemed to be somewhat prolonged after transplantation, but also after treatment with Azathioprine alone. Table 1 . t~esults of oral glucose tolerance tests Blood sugar and IRI values were measured before and 35 rain after oral glucose (2 g/kg). 60 rain prior to the administration of oral glucose a trace amount (40 ~zCi) of glucose-U-i4C was given intravenously, and the biological half life of blood glucose (T 89 was graphically deterrained on semflogarithmie paper by plotting the fall in radioactive glucose per ml of blood after oral glucose administration 40  24  94  13  86  41  Control  211  26  86  13  154  26  259  38  80  13  92  23  Immunosuppressive  83  34  81  13  therapy  120  21  Transplanted  45  43  69  11  venous drainage  88  18  into inferior  211  39  106  19  vena cava  115  21  Transplanted  259  77  46  11  venous drainage  85  12  into portal vein Serum IRI was about doubled 10 rain after intravenous glucose in the control group, and the insulin release from the transplanted pancreas was of the same order of magnitude. Azathioprine alone appeared to have no effect on IRI levels.
Discussion
The endocrine function of the transplanted pancreas has previously been studied by the measurement of postoperative blood sugar levels [2, 19, 20, 21] , as well as by intravenous glucose tolerance tests and the determination of IRI-levels [9, 19] . Our data obtained by the same methods indicate that a transplanted dog pancreas is indeed able to enhance insulin release in response to systemic hyperglycaemia and confirms the findings o~ Ota et al. [9, 19] .
The duodeno-pancreatie complex not only represents an anatomical and surgical unit, but also a physiological one. It is well known that the duodenum plays an important role in the humeral control of exocrine as well as endocrine pancreatic function. The technique used for duodeno-pancreatic transplantation in our experiments was developped by LargiadSr and coworkers [14] with the intention to preserve both the endocrine and the exocrine function of the graft. As a further advantage of this method, no pancreatic regeneration is possible after duodeno-pancreatectomy as had been reported when other techniques were used [2] . The investigation of the function of the glucoseresponsive "entero-insular axis" [18] by oral glucose administration revealed that although the glucose assimilation rate was somewhat increased in response to the insulino-secretory stimulus, IRI-levels remained essentially unchanged. Table 2 . Results of intravenous glucose tolerance tests Blood sugar and IRI values were measured before, 10 and 30 rain after intravenous glucose administration (0.5 g/kg). Again, a trace amount (40 ~Ci) of glueose-U-i4C was given intravenously 60 min before the tolerance tests, and T 89 of blood glucose was determined as explained in the legend to 64  13  3  25  162  36  77  11  74  14  123  30  192  28  139  28  Control  48  13  305  42  105  38  70  22  72  11  279  17  180  27  83  10  84  9  86  37  183  21  118  24  70  9  Imtnunosuppressive  3  39  189  27  therapy  135  9  80  12  123 40  172  56  123  22  63  20  173 41  148  --106  26  Transplanted  66  9  venous drainage into  x  36  162  32  inferior vena cava  104  19  65  9  86  75  147  22  121  19 An impairment of glucose resorption cannot be the only cause for the deficient insulin response, since blood sugar values after glucose loads were not higher in the control group than in the transplanted dogs, and yet IRI values were twice as high. Thus, our results are in agreement with the conclusion of Arnould [1] that the pancreatic response to oral glucose in dogs is influenced by intestinal factors as well as by systemic hyperglycaemia. In dogs with pancreatico-duodenal transplantation this regulatory intestinal function seems to be impaired. It has previously been observed by post mortem examination that the immunological reaction of the pancreas is less pronounced than that of the duodenum. In our study, four out of ten dogs died after transplantation because of severe ulcerating inflammation of the duodenum [13] .
One may conclude, therefore, that the pancreaticoduodenal grafts are unable to respond in a normal manner to oral glucose because of the signs of immunological rejection of the duodenum, whereas the more resistant B-ceils may be stimulated by systemic hyperglycaemia.
By the surgical technique routinely used in this study, the vena portae of the graft was implanted into the vena cava of the recipient animal, so that the pancreatico-duodenal venous blood bypassed the liver. The effect of the porto-caval shunt on glucose metabolism has repeatedly been studied [9, 15, 16, 22] . No clear cut effects of porto-caval transposition on the fasting blood sugar values and on the glucose assimilation rate were observed by Lorenz et al. [15] .
In our series one porto-portal anastomosis was performed. We failed to observe any difference in the carbohydrate metabolism in this animal and the metabolism in the other transplanted dogs. Thus, our results confirm the observation of Jdezuki et al. [9] .
Pancreatico-duodenal transplantation has already been therapeutically used for the treatment of "severe human diabetes mellitus and its complications" [10, 11] . The patients required no insulin treatment for 31 to 134 days postoperatively. Since immunological complications affecting the duodenum seem to be present long before failure of the B-cells becomes apparent, we still have a long way to go before pancreatico-duodenal transplantation might become a feasible therapeutic tool in the treatment of diabetics. However, transplantation of the pancreas continues to be an interesting experimental means for the study of the pathophysiology of diabetes mellitus, as it was already in Minkowski's times.
